Skip to content
PubMed This is a summary of 82 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 82 referenced papers

Top Authors

Bodo Grimbacher
University of Freiburg
Asghar Aghamohammadi
Children's Medical Center
Klaus Warnatz
University of Freiburg
Vassilios Lougaris
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Fabian H. Hauck
LMU Klinikum
Laia Alsina
Hospital Sant Joan de Déu Barcelona
Hassan Abolhassani
Karolinska Institutet
Charlotte Cunningham‐Rundles
Icahn School of Medicine at Mount Sinai
Gholamreza Azizi
Alborz University of Medical Sciences
Siobhan Oisin Burns
Royal Free London NHS Foundation Trust

Top Institutions

Ranked by publications Top 10 institutions
10

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Brescia, Italy

36 papers

References

References (82)
  1. 1

    Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

    Bride KL, Vincent T, Smith-Whitley K, et al.

    Blood 2016; (127(1)):17-28 doi:10.1182/blood-2015-07-657981.

    PMID: 26504182
  2. 2

    The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.

    Sharifi L, Mirshafiey A, Rezaei N, et al.

    Expert review of clinical immunology 2016; (12(2)):195-207 doi:10.1586/1744666X.2016.1114885.

    PMID: 26654573
  3. 3

    How to use immunoglobulin levels in investigating immune deficiencies.

    Ladomenou F, Gaspar B

    Archives of disease in childhood. Education and practice edition 2016; (101(3)):129-35 doi:10.1136/archdischild-2015-309060.

    PMID: 26987724
  4. 4

    NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.

    Boztug H, Hirschmugl T, Holter W, et al.

    Journal of clinical immunology 2016; (36(6)):533-40 doi:10.1007/s10875-016-0306-1.

    PMID: 27338827
  5. 5

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  6. 6

    Increased Incidence of Fatigue in Patients with Primary Immunodeficiency Disorders: Prevalence and Associations Within the US Immunodeficiency Network Registry.

    Hajjar J, Guffey D, Minard CG, Orange JS

    Journal of clinical immunology 2017; (37(2)):153-165 doi:10.1007/s10875-016-0367-1.

    PMID: 28124237
  7. 7

    The TH1 phenotype of follicular helper T cells indicates an IFN-γ-associated immune dysregulation in patients with CD21low common variable immunodeficiency.

    Unger S, Seidl M, van Schouwenburg P, et al.

    The Journal of allergy and clinical immunology 2018; (141(2)):730-740 doi:10.1016/j.jaci.2017.04.041.

    PMID: 28554560
  8. 8

    Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.

    Burnett DL, Parish IA, Masle-Farquhar E, et al.

    Immunology and cell biology 2017; (95(9)):775-788 doi:10.1038/icb.2017.50.

    PMID: 28611475
  9. 9

    Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency.

    Azizi G, Abolhassani H, Kiaee F, et al.

    Allergologia et immunopathologia 2018; (46(2)):127-135 doi:10.1016/j.aller.2017.04.004.

    PMID: 28735808
  10. 10

    Infectious complications of rituximab therapy in renal disease.

    Nixon A, Ogden L, Woywodt A, Dhaygude A

    Clinical kidney journal 2017; (10(4)):455-460 doi:10.1093/ckj/sfx038.

    PMID: 28852481
  11. 11

    Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.

    Pecoraro A, Crescenzi L, Granata F, et al.

    International immunopharmacology 2017; (52()):136-142 doi:10.1016/j.intimp.2017.09.005.

    PMID: 28898770
  12. 12

    Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study.

    Schmidt M, Schellongowski P, Patroniti N, et al.

    American journal of respiratory and critical care medicine 2018; (197(10)):1297-1307 doi:10.1164/rccm.201708-1761OC.

    PMID: 29298095
  13. 13

    Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.

    Tuijnenburg P, Lango Allen H, Burns SO, et al.

    The Journal of allergy and clinical immunology 2018; (142(4)):1285-1296 doi:10.1016/j.jaci.2018.01.039.

    PMID: 29477724
  14. 14

    [Cutaneous manifestations in primary immunodeficiency diseases].

    Bojtor AE, Sárdy M, Maródi L

    Orvosi hetilap 2018; (159(23)):937-947 doi:10.1556/650.2018.30994.

    PMID: 29860885
  15. 15

    Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond.

    de Valles-Ibáñez G, Esteve-Solé A, Piquer M, et al.

    Frontiers in immunology 2018; (9()):636 doi:10.3389/fimmu.2018.00636.

    PMID: 29867916
  16. 16

    Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses.

    Romberg N, Le Coz C, Glauzy S, et al.

    The Journal of allergy and clinical immunology 2019; (143(1)):258-265 doi:10.1016/j.jaci.2018.06.012.

    PMID: 29935219
  17. 17

    Differing Performance of the Warning Signs for Immunodeficiency in the Diagnosis of Pediatric Versus Adult Patients in a Two-Center Tertiary Referral Population.

    Bjelac JA, Yonkof JR, Fernandez J

    Journal of clinical immunology 2019; (39(1)):90-98 doi:10.1007/s10875-018-0582-z.

    PMID: 30610441
  18. 18

    Neurological Involvement in Childhood Evans Syndrome.

    Pincez T, Neven B, Le Pointe HD, et al.

    Journal of clinical immunology 2019; (39(2)):171-181 doi:10.1007/s10875-019-0594-3.

    PMID: 30671780
  19. 19

    Health-Related Quality of Life and Emotional Health in X-Linked Carriers of Chronic Granulomatous Disease in the United Kingdom.

    Battersby AC, Braggins H, Pearce MS, et al.

    Journal of clinical immunology 2019; (39(2)):195-199 doi:10.1007/s10875-019-00607-6.

    PMID: 30868346
  20. 20

    Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review.

    Habibi S, Zaki-Dizaji M, Rafiemanesh H, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(7)):2379-2386.e5 doi:10.1016/j.jaip.2019.04.011.

    PMID: 30995531
  21. 21

    Immunosuppressive therapy with rituximab in common variable immunodeficiency.

    Pecoraro A, Crescenzi L, Galdiero MR, et al.

    Clinical and molecular allergy : CMA 2019; (17()):9 doi:10.1186/s12948-019-0113-3.

    PMID: 31080365
  22. 22

    [Treatment of ITP and AIHA in CVID: A systematic literature review].

    Lacombe V, Lozac'h P, Orvain C, et al.

    La Revue de medecine interne 2019; (40(8)):491-500 doi:10.1016/j.revmed.2019.02.006.

    PMID: 31101329
  23. 23

    EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

    van Dongen JJM, van der Burg M, Kalina T, et al.

    Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.

    PMID: 31263462
  24. 24

    Autoimmunity in common variable immunodeficiency.

    Agarwal S, Cunningham-Rundles C

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(5)):454-460 doi:10.1016/j.anai.2019.07.014.

    PMID: 31349011
  25. 25

    Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside.

    Delmonte OM, Castagnoli R, Calzoni E, Notarangelo LD

    Frontiers in pediatrics 2019; (7()):353 doi:10.3389/fped.2019.00353.

    PMID: 31508401
  26. 26

    Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders.

    Malpica L, van Duin D, Moll S

    American journal of hematology 2019; (94(12)):1396-1412 doi:10.1002/ajh.25642.

    PMID: 31571266
  27. 27

    Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.

    Edwards ESJ, Bosco JJ, Aui PM, et al.

    Frontiers in immunology 2019; (10()):2593 doi:10.3389/fimmu.2019.02593.

    PMID: 31803177
  28. 28

    [Enteroviral infections in adults treated with rituximab: A new case of chronic meningitis and myofasciitis and literature review].

    Maillet F, Pineton De Chambrun M, Monzani Q, et al.

    La Revue de medecine interne 2020; (41(3)):200-205 doi:10.1016/j.revmed.2019.12.018.

    PMID: 31980187
  29. 29

    Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies.

    Pecoraro A, Ricci S, Vultaggio A, et al.

    Clinical drug investigation 2020; (40(3)):279-286 doi:10.1007/s40261-020-00885-8.

    PMID: 32036588
  30. 30

    Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.

    Lorenzini T, Fliegauf M, Klammer N, et al.

    The Journal of allergy and clinical immunology 2020; (146(4)):901-911 doi:10.1016/j.jaci.2019.11.051.

    PMID: 32278790
  31. 31

    Tonsillar granuloma associated with hypogammaglobulinemia.

    Laajala A, Kuismin O, Tastula M, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2020; (16()):43 doi:10.1186/s13223-020-00441-1.

    PMID: 32514274
  32. 32

    Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.

    Hanitsch L, Baumann U, Boztug K, et al.

    European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.

    PMID: 32845010
  33. 33

    Next-generation sequencing for inborn errors of immunity.

    Lee K, Abraham RS

    Human immunology 2021; (82(11)):871-882 doi:10.1016/j.humimm.2021.02.011.

    PMID: 33715910
  34. 34

    State-of-the-art diagnostic evaluation of common variable immunodeficiency.

    Lee TK, Gereige JD, Maglione PJ

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2021; (127(1)):19-27 doi:10.1016/j.anai.2021.03.005.

    PMID: 33716149
  35. 35

    Severe Fatigue Is Common Among Pediatric Patients with Primary Immunodeficiency and Is Not Related to Disease Activity.

    Nijhof LN, van Brussel M, Pots EM, et al.

    Journal of clinical immunology 2021; (41(6)):1198-1207 doi:10.1007/s10875-021-01013-7.

    PMID: 33728554
  36. 36

    Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis.

    Dumas G, Lemiale V, Rathi N, et al.

    American journal of respiratory and critical care medicine 2021; (204(2)):187-196 doi:10.1164/rccm.202009-3575OC.

    PMID: 33751920
  37. 37

    Perspective: Application of the American College of Medical Genetics Variant Interpretation Criteria to Common Variable Immunodeficiency Disorders.

    Ameratunga R, Allan C, Lehnert K, Woon ST

    Clinical reviews in allergy & immunology 2021; (61(2)):226-235 doi:10.1007/s12016-020-08828-z.

    PMID: 33818703
  38. 38

    Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.

    Zama D, Conti F, Moratti M, et al.

    Immunity, inflammation and disease 2021; (9(2)):583-594 doi:10.1002/iid3.420.

    PMID: 33838017
  39. 39

    Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.

    Westermann-Clark E, Meehan CA, Meyer AK, et al.

    Frontiers in immunology 2021; (12()):649182 doi:10.3389/fimmu.2021.649182.

    PMID: 33968040
  40. 40

    Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: A 2-year real-life experience.

    Vivarelli E, Matucci A, Bormioli S, et al.

    Clinical and experimental immunology 2021; (205(3)):346-353 doi:10.1111/cei.13629.

    PMID: 34061980
  41. 41

    Therapeutic options for CTLA-4 insufficiency.

    Egg D, Rump IC, Mitsuiki N, et al.

    The Journal of allergy and clinical immunology 2022; (149(2)):736-746 doi:10.1016/j.jaci.2021.04.039.

    PMID: 34111452
  42. 42

    There is no gene for CVID - novel monogenetic causes for primary antibody deficiency.

    Ramirez NJ, Posadas-Cantera S, Caballero-Oteyza A, et al.

    Current opinion in immunology 2021; (72()):176-185 doi:10.1016/j.coi.2021.05.010.

    PMID: 34153571
  43. 43

    Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency.

    Berbers RM, van der Wal MM, van Montfrans JM, et al.

    Journal of clinical immunology 2021; (41(7)):1621-1632 doi:10.1007/s10875-021-01084-6.

    PMID: 34247288
  44. 44

    The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency.

    Robbins A, Bahuaud M, Hentzien M, et al.

    Frontiers in immunology 2021; (12()):697128 doi:10.3389/fimmu.2021.697128.

    PMID: 34290713
  45. 45

    [Prophylactic and therapeutic management of increased susceptibility to infection in patients with immunodeficiency].

    Hanitsch LG

    Der Internist 2022; (63(5)):484-492 doi:10.1007/s00108-022-01326-8.

    PMID: 35412057
  46. 46

    Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets.

    Cortesi M, Soresina A, Dotta L, et al.

    Frontiers in immunology 2022; (13()):846660 doi:10.3389/fimmu.2022.846660.

    PMID: 35464467
  47. 47

    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.

    Cornelissen HM, Musekwa EM, Glashoff RH, et al.

    British journal of haematology 2022; (198(5)):875-886 doi:10.1111/bjh.18337.

    PMID: 35791731
  48. 48

    Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update.

    Chawla S, Barman P, Tyagi R, et al.

    Frontiers in immunology 2022; (13()):869466 doi:10.3389/fimmu.2022.869466.

    PMID: 35795667
  49. 49

    "Common variable immunodeficiency: Challenges for diagnosis".

    Wang LA, Abbott JK

    Journal of immunological methods 2022; (509()):113342 doi:10.1016/j.jim.2022.113342.

    PMID: 36027932
  50. 50

    Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab.

    Athni TS, Barmettler S

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2023; (130(6)):699-712 doi:10.1016/j.anai.2023.01.018.

    PMID: 36706910
  51. 51

    Perceived Sleep Quality in Individuals with Inborn Errors of Immunity.

    Sowers KL, Sawaged A, Bowen B

    Journal of clinical immunology 2023; (43(6)):1221-1228 doi:10.1007/s10875-023-01474-y.

    PMID: 36959490
  52. 52

    ANCA vasculitis expands the spectrum of autoimmune manifestations of activated PI3 kinase δ syndrome.

    Sood AK, Francis O, Schworer SA, et al.

    Frontiers in pediatrics 2023; (11()):1179788 doi:10.3389/fped.2023.1179788.

    PMID: 37274825
  53. 53

    Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease.

    Daza-Cajigal V, Segura-Guerrero M, López-Cueto M, et al.

    Frontiers in immunology 2023; (14()):1197361 doi:10.3389/fimmu.2023.1197361.

    PMID: 37342345
  54. 54

    Perceived control is significantly associated with psychological adaptation in individuals with known or suspected inborn errors of immunity.

    Setzer M, Yan J, Erby L, Similuk M

    Journal of community genetics 2023; (14(6)):639-647 doi:10.1007/s12687-023-00670-y.

    PMID: 37709977
  55. 55

    Patient-reported outcomes in patients with primary immunodeficiency diseases in Japan: baseline results from a prospective observational study.

    Kanegane H, Ishimura M, Kawai T, et al.

    Frontiers in immunology 2023; (14()):1244250 doi:10.3389/fimmu.2023.1244250.

    PMID: 37828988
  56. 56

    Infections in Disorders of Immune Regulation.

    Thangaraj A, Tyagi R, Suri D, Gupta S

    Pathogens (Basel, Switzerland) 2024; (13(3)) doi:10.3390/pathogens13030259.

    PMID: 38535602
  57. 57

    Assessment of Sleep Disorders in Patients with CVID.

    Punj M, Neshat SS, Mateus AYL, et al.

    Journal of clinical immunology 2024; (44(5)):109 doi:10.1007/s10875-024-01711-y.

    PMID: 38676767
  58. 58

    A qualitative study to explore the burden of disease in activated phosphoinositide 3-kinase delta syndrome (APDS).

    Hitchcock I, Skrobanski H, Matter E, et al.

    Orphanet journal of rare diseases 2024; (19(1)):203 doi:10.1186/s13023-024-03215-9.

    PMID: 38760658
  59. 59

    Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study.

    Tsilifis C, Speckmann C, Lum SH, et al.

    The Journal of allergy and clinical immunology 2024; (154(6)):1534-1544 doi:10.1016/j.jaci.2024.08.020.

    PMID: 39218359
  60. 60

    Immunoglobulin therapy for immunodeficiency.

    Wilson BE, Freeman CM

    Allergy and asthma proceedings 2024; (45(5)):364-370 doi:10.2500/aap.2024.45.240053.

    PMID: 39294913
  61. 61

    Prolonged Severe CD4+ Lymphocytopenia and Hypogammaglobulinemia in Patients With Evans' Syndrome: A Case Report.

    Kurokawa T, Imoto N, Muramatsu H, Shingo K

    Cureus 2024; (16(12)):e75283 doi:10.7759/cureus.75283.

    PMID: 39764316
  62. 62

    What intensivists need to know about cytomegalovirus infection in immunocompromised ICU patients.

    Fernández S, Castro P, Azoulay E

    Intensive care medicine 2025; (51(1)):39-61 doi:10.1007/s00134-024-07737-5.

    PMID: 39774866
  63. 63

    Inborn errors of immunity (primary immunodeficiencies).

    Kim VHD, Upton JEM, Derfalvi B, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2025; (20(Suppl 3)):76 doi:10.1186/s13223-024-00938-z.

    PMID: 39780212
  64. 64

    Common variable immunodeficiency and autoimmune diseases: A 10-year single-center experience.

    Sadi Aykan F, Çölkesen F, Evcen R, et al.

    Archives of rheumatology 2024; (39(4)):588-597 doi:10.46497/ArchRheumatol.2024.10729.

    PMID: 40060126
  65. 65

    Prospective Evaluation of Clinical and Laboratory Profiles of Febrile and Afebrile Immunosuppressed Patients Presenting to the Emergency Department.

    Topal T, Pamukçu E, Turtay MG, et al.

    Medicina (Kaunas, Lithuania) 2025; (61(5)) doi:10.3390/medicina61050889.

    PMID: 40428847
  66. 66

    Clinical, immunological, and genetic landscape of common variable immunodeficiency in Morocco: a nationwide multicenter study.

    Allaoui A, Moundir A, Benhsaien I, et al.

    Frontiers in immunology 2025; (16()):1602820 doi:10.3389/fimmu.2025.1602820.

    PMID: 40703516
  67. 67

    Intrathymic T-cell ontogeny: Crossroad between immune competence and tolerance.

    Giardino G, Romano R, Grilli L, et al.

    The Journal of allergy and clinical immunology 2025; (156(6)):1489-1499 doi:10.1016/j.jaci.2025.10.007.

    PMID: 41138923
  68. 68

    Management of the child with primary immunodeficiency.

    Lehman HK, Khaira A, Kaur S

    Current opinion in pediatrics 2025; (37(6)):606-612 doi:10.1097/MOP.0000000000001513.

    PMID: 41190402
  69. 69

    Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.

    Gaál Z, Meehan C, Yilmaz M, et al.

    Pediatric blood & cancer 2026; (73(3)):e70074 doi:10.1002/1545-5017.70074.

    PMID: 41560547
  70. 70

    [Chinese expert consensus on the diagnosis and treatment of severe pneumonia in immunocompromised hosts].

    ,

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2026; (49(2)):113-130 doi:10.3760/cma.j.cn112147-20250729-00449.

    PMID: 41629088
  71. 71

    Vulnerability beyond infection: Effects of peer victimization on quality of life and psychosocial well-being in inborn errors of immunity.

    Meric Z, Durcan G, Coban ZB, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(3)):e70318 doi:10.1111/pai.70318.

    PMID: 41800593
  72. 72

    Diagnostic odyssey of patients with the rare immunodeficiency activated PI3 kinase delta syndrome (APDS): case study from expert and patient surveys.

    Wolf HM, Candotti F, Spelsberg R, et al.

    Frontiers in immunology 2026; (17()):1763482 doi:10.3389/fimmu.2026.1763482.

    PMID: 41859081
  73. 73

    Pediatric Evans Syndrome as a Multisystem Immune Disorder: A 13-Year Longitudinal Experience from a Single Academic Center.

    Karamitsos D, Papandrea IP, Rokidi N, et al.

    Pediatric reports 2026; (18(2)) doi:10.3390/pediatric18020034.

    PMID: 41874013
  74. 74

    Inborn errors of immunity at school: How can we do better?

    Lopez-Seguer L, Rodriguez-Tello S, Gonzalez-Amores M, et al.

    Journal of human immunity 2026; (2(3)):e20250120 doi:10.70962/jhi.20250120.

    PMID: 42170002
  75. 75

    The burden of severe leukocyte adhesion deficiency, type I (LAD-I): A multiple-case study from the caregiver's perspective.

    O'Connor M, Simas C, Keith M, et al.

    Journal of human immunity 2026; (2(4)):e20260022 doi:10.70962/jhi.20260022.

    PMID: 42254725
  76. 76

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  77. 77

    Psychological Symptoms in Patients with Inborn Errors of Immunity and Their Family Members: A Cross-Sectional Study.

    Alpagat G, Nas N

    Medicina (Kaunas, Lithuania) 2026; (62(8)) doi:10.3390/medicina62081616.

    PMID: 42654513
  78. 78

    Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

    Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.

    Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.

    PMID: 42676356
  79. 79

    Dual Autoimmunity: Evans Syndrome and Multiple Sclerosis.

    Markl A, Warren M, Iskander J, et al.

    Cureus 2026; (18(8)):e113997 doi:10.7759/cureus.113997.

    PMID: 42698986
  80. 80

    Frequency of depression and anxiety in patients with inborn errors of immunity: a cross-sectional study.

    Wolff LJ, Witte T, Kahl KG, et al.

    BMC psychiatry 2026; (26(1)).

    PMID: 42745244
  81. 81

    Immune Checkpoint Dysfunction Remodels Adaptive Immune Receptor Repertoires in CTLA-4 Insufficiency and LRBA Deficiency.

    Cildir G, Cildir S, Erdogan RK, et al.

    Clinical reviews in allergy & immunology 2026; (69(1)).

    PMID: 42895678
  82. 82

    Work participation in inborn errors of immunity: The dual burden on patients and caregivers.

    Pulvirenti F, Sgrulletti M, Radovic K, et al.

    Journal of human immunity 2026; (2(6)) doi:10.70962/jhi.20260077.

    PMID: 42911122